| Latest Edwards Lifesciences News Headlines | | Date | Time | Source | | | 07/22/2008 | 4:01PM | PRNUS | Edwards Lifesciences Reports Strong Second Quarter Results and Raises Full Year Outlook - 20 Percent Reported Sales Growth
IRVINE, Calif., July 22 /PRNewswire-FirstCall/ -- Edwards Lifesciences Corporation (NYSE:EW), a world leader in products and technologies to treat advanced cardiovascular disease, today reported net income for the quarter ended June 30, 2008 of $39.7 million, or $0.67 per diluted share... More...>> |
| 07/15/2008 | 9:00AM | PRNUS | Edwards Lifesciences to Host Earnings Conference Call on July 22, 2008
IRVINE, Calif., July 15 /PRNewswire-FirstCall/ -- Edwards Lifesciences Corporation (NYSE:EW), a world leader in products and technologies to treat advanced cardiovascular disease, plans to announce its operating results for the quarter ended June 30, 2008 after the market closes on Tuesday, July 22, 2008 and will host... More...>> |
| 07/11/2008 | 9:00AM | PRNUS | Edwards Lifesciences' Board Approves New $250 Million Share Repurchase Program
IRVINE, Calif., July 11 /PRNewswire-FirstCall/ -- Edwards Lifesciences Corporation (NYSE:EW), a world leader in products and technologies to treat advanced cardiovascular disease, announced today that its board of directors has authorized a new share repurchase program to acquire up to $250 million of the company's... More...>> |
| 06/17/2008 | 1:49PM | PRNUS | Edwards Lifesciences to Present at the 18th Annual Wachovia Nantucket Equity Conference
IRVINE, Calif., June 17 /PRNewswire-FirstCall/ -- Edwards Lifesciences Corporation (NYSE:EW), a world leader in products and technologies to treat advanced cardiovascular disease, is scheduled to participate in the 18th Annual Wachovia Nantucket Equity Conference at the White Elephant Hotel in Nantucket, Massachusetts... More...>> |
| 06/04/2008 | 1:00PM | PRNUS | Edwards Lifesciences to Present at the Goldman Sachs 29th Annual Global Healthcare Conference
IRVINE, Calif., June 4 /PRNewswire-FirstCall/ -- Edwards Lifesciences Corporation (NYSE:EW), a world leader in products and technologies to treat advanced cardiovascular disease, is scheduled to participate in the Goldman Sachs 29th Annual Global Healthcare Conference at the Ritz-Carlton Laguna Niguel Hotel in Dana... More...>> |
| 05/30/2008 | 2:00PM | PRNUS | Edwards Lifesciences Receives Additional Questions From the FDA About the LifeStent Product Line
IRVINE, Calif., May 30 /PRNewswire-FirstCall/ -- Edwards Lifesciences Corporation (NYSE:EW), a world leader in products and technologies to treat advanced cardiovascular disease, said today that it has received additional questions from the U.S. Food and Drug Administration (FDA) regarding the company's submission for... More...>> |
| 05/22/2008 | 9:00AM | PRNUS | Edwards Lifesciences Opens New Singapore Heart Valve Facility
SINGAPORE, May 22 /PRNewswire-FirstCall/ -- Edwards Lifesciences Corporation (NYSE:EW), the world leader in the science of heart valves, today announced the opening of its new heart valve manufacturing facility in Changi North Crescent, Singapore. The state-of-the-art facility produces Edwards' world-leading Carpentier-Edwards... More...>> |
| 05/12/2008 | 9:00AM | PRNUS | Edwards Lifesciences Introduces New Transcatheter Valve Delivery System at EuroPCR 2008 Scientific Program Highlights: Establishing a Transcatheter Program, MONARC Feasibility Update
IRVINE, Calif. and BARCELONA, Spain, May 12 /PRNewswire-FirstCall/ -- Edwards Lifesciences Corporation (NYSE:EW), the world leader in the science of heart valves, announced the launch of the company's next-generation transfemoral... More...>> |
| 05/08/2008 | 4:52PM | PRNUS | Edwards Lifesciences Celebrates One Million Heart Valve Patients and More at AATS 2008
IRVINE, Calif., May 8 /PRNewswire-FirstCall/ -- Edwards Lifesciences Corporation (NYSE:EW), the world leader in the science of heart valves, announced that the company will celebrate a number of cardiac surgery milestones and product debuts at the 88th annual meeting of the American Association for Thoracic Surgery... More...>> |
| 05/01/2008 | 1:15PM | PRNUS | Edwards Lifesciences to Webcast Annual Stockholders Meeting
IRVINE, Calif., May 1 /PRNewswire-FirstCall/ -- Edwards Lifesciences Corporation (NYSE:EW), a world leader in products and technologies to treat advanced cardiovascular disease, will host its Annual Meeting of Stockholders on Thursday, May 8, 2008 beginning at 10:00 a.m. PT (1:00 pm ET) at the corporate headquarters... More...>> |
| 04/24/2008 | 9:00AM | PRNUS | Edwards Lifesciences to Present at the Morgan Stanley Global Healthcare Unplugged Conference
IRVINE, Calif., April 24 /PRNewswire-FirstCall/ -- Edwards Lifesciences Corporation (NYSE:EW), a world leader in products and technologies to treat advanced cardiovascular disease, is scheduled to participate in the Morgan Stanley Global Healthcare Unplugged Conference at the Ritz-Carlton Key Biscayne Hotel in Florida... More...>> |
| 04/22/2008 | 4:01PM | PRNUS | Edwards Lifesciences Reports Strong First Quarter Results and Raises 2008 Guidance - Strong Sales Growth Across All Product Lines
IRVINE, Calif., April 22 /PRNewswire-FirstCall/ -- Edwards Lifesciences Corporation (NYSE:EW), a world leader in products and technologies to treat advanced cardiovascular disease, today reported net income for the quarter ended March 31, 2008 of $18.2 million, or $0.31... More...>> |
| 04/18/2008 | 9:00AM | PRNUS | Edwards Lifesciences Announces First Implants in U.S. Study of Minimally-Invasive Pulmonic Valve
IRVINE, Calif., April 18 /PRNewswire-FirstCall/ -- Edwards Lifesciences Corporation (NYSE:EW), the world leader in the science of heart valves, announced that yesterday the first patients were treated in a United States feasibility study using the Edwards SAPIEN transcatheter heart valve in addressing a congenital condition... More...>> |
| 04/16/2008 | 9:00AM | PRNUS | Edwards Lifesciences Announces Retirement of Director Vernon Loucks
IRVINE, Calif., April 16 /PRNewswire-FirstCall/ -- Edwards Lifesciences Corporation (NYSE:EW), a world leader in the products and technologies to treat advanced cardiovascular disease, announced today that Vernon R. Loucks Jr. is retiring from the company's board of directors, effective May 31, 2008.
Loucks, who is... More...>> |
| 04/15/2008 | 1:30PM | PRNUS | Edwards Lifesciences to Host Earnings Conference Call on April 22, 2008
IRVINE, Calif., April 15 /PRNewswire-FirstCall/ -- Edwards Lifesciences Corporation (NYSE:EW), a global leader in products and technologies to treat advanced cardiovascular disease, plans to announce its operating results for the quarter ended March 31, 2008 after the market closes on Tuesday, April 22, 2008 and will... More...>> |
| 04/03/2008 | 9:10AM | PRNUS | Edwards Lifesciences Celebrates 50 Years of Life-Saving Innovations - Chairman and CEO Honors the Anniversary by Ringing The Closing Bell(R) at the NYSE on April 4 -
IRVINE, Calif., April 3, 2008 /PRNewswire-FirstCall/ -- Edwards Lifesciences Corporation (NYSE:EW), a world leader in products and technologies to treat advanced cardiovascular disease, today announced its 50th anniversary... More...>> |
| 04/03/2008 | 9:00AM | PRNUS | Edwards Lifesciences' Chairman and CEO Adopts New 10b5-1 Stock Trading Plan to Replace Recently Expired Plan
IRVINE, Calif., April 3, 2008 /PRNewswire-FirstCall/ -- Edwards Lifesciences Corporation (NYSE:EW), a global leader in products and technologies to treat advanced cardiovascular disease, today announced that its chairman and chief executive officer, Michael A. Mussallem, has adopted a pre-arranged stock trading plan... More...>> |
| 03/14/2008 | 1:30PM | PRNUS | Edwards Lifesciences to Present at the Citi 5th Annual Small and Mid-Cap Conference
IRVINE, Calif., March 14 /PRNewswire-FirstCall/ -- Edwards Lifesciences Corporation (NYSE:EW), a world leader in products and technologies to treat advanced cardiovascular disease, is scheduled to participate in the Citi 5th Annual Small and Mid-Cap Conference at the Four Seasons Hotel in Las Vegas on Wednesday, March... More...>> |
| 03/13/2008 | 10:30AM | PRNUS | Edwards Lifesciences' CEO Begins Two-Year Term as Chairman of AdvaMed
IRVINE, Calif., March 13 /PRNewswire-FirstCall/ -- Edwards Lifesciences Corporation (NYSE:EW), a world leader in products and technologies to treat advanced cardiovascular disease, today announced that Michael A. Mussallem, the company's chairman and CEO, was elected to a two-year term as chairman of the board of directors... More...>> |
| 03/11/2008 | 3:30PM | PRNUS | Edwards Lifesciences to Present at the Cowen and Company Annual Healthcare Conference
IRVINE, Calif., March 11 /PRNewswire-FirstCall/ -- Edwards Lifesciences Corporation (NYSE:EW), a world leader in products and technologies to treat advanced cardiovascular disease, is scheduled to participate in the Cowen and Company Annual Healthcare Conference at the Marriott Copley Place Hotel in Boston on Tuesday... More...>> |
|